Why small vaccine doses are now the norm in aquaculture
In the last 20 years, fish vaccine doses have got smaller, and at some pace. From 0.2ml once being the industry standard to 0.05ml the most seen now, and some 0.025ml products available, there has been a clear direction of travel. Nils Steine, business unit director for PHARMAQ, explains why.
Health & Welfare
Vaccine ‘work in progress’ in major aquaculture markets, Part 3: Atlantic salmon
While there are efficacious commercial vaccines available against a number of important diseases that affect Atlantic salmon, there are still pathogens for which there are currently no such options available.
Vaccine ‘work in progress’ in major aquaculture markets, Part 2: Tilapia
Nile tilapia is now the second most farmed fish worldwide, in part due to its adaptability. It is, however, susceptible to a number of diseases.
Mycobacteriosis could prove growing problem in aquaculture
Intensification of aquaculture and domestication of wild species are leading to an increased prevalence of mycobacteriosis in farmed aquatic invertebrates, according to a review of the disease’s emergence by an international team of researchers.
Why fish vaccines are increasingly coming in smaller doses
An interview with Dr Bjørn Brudeseth, PhD, PHARMAQ
Taming tilapia lake virus requires improved expert collaboration
Tilapia lake virus (TiLV) is an emerging threat to aquaculture, having been discovered in 2014 and now reported in 16 countries.
China making up for lost time in aquatic vaccine development
China is now responsible for over 70% of global farmed-fish production. Finding appropriate responses to fish disease has not been as rapid, researchers from Huazhong Agricultural University acknowledged — but new options in development suggest that the nation is fast catching up.
Cleaner-fish health risks highlighted as use in aquaculture rises
Cleaner fish have proved an effective alternative method of sea louse control — but their widespread introduction brings with it a new threat of pathogens and parasites, and available treatments are falling short of requirements.
- « Previous
- 1
- …
- 3
- 4
- 5